General Management of Complex Wounds

2014 ◽  
pp. 10-16 ◽  
Author(s):  
Jeffrey Janis ◽  
Bridget Harrison
Keyword(s):  
General Management ◽  
Complex Wounds

Penerapan Proses Keperawatan di Rumah Sakit dalam Meningkatkan Mutu Keperawatan

2020 ◽  
Author(s):  
Kristin Natal Riang Gea
Keyword(s):  
Quality Of Service ◽  
Nursing Care ◽  
Appropriate Technology ◽  
Nursing Process ◽  
General Management ◽  
Management Concepts ◽  
Optimal Health ◽  
Service Standards ◽  
Management Of Care

AbstrakManajemen asuhan keperawatan merupakan suatu proses keperawatan yang menggunakan konsep manajemen secara umum didalamnya seperti perencanaan, pengorganisasian, pengarahan dan pengendalian atau evaluasi. Peningkatan mutu pelayanan adalah derajat memberikan pelayanan secara efisien dan efektif sesuai dengan standar profesi, standar pelayanan yang dilaksanakan secara menyeluruh sesuai dengan kebutuhan pasien, memanfaatkan teknologi tepat guna dan hasil penelitian dalam pengembangan pelayanan kesehatan/ keperawatan sehingga tercapai derajat kesehatan yang optimal. Kualitas pelayanan keperawatan di rumah sakit tidak akan berjalan dengan baik apabila proses keperawatan yang dilaksanakan tidak terstruktur dengan baikKata Kunci : Manajemen Keperawatan, Kualitas Pelayanan,.standar proses keperawatanAbstract Nursing care management is a nursing process that uses general management concepts in it such as planning, organizing, directing and controlling or evaluation. Improving the quality of service is the degree of providing services in an efficient and effective in accordance with professional standards, service standards are implemented thoroughly in accordance with the needs of patients, utilizing appropriate technology and research results in the development of health services / nursing to achieve optimal health. The quality of nursing care in the hospital will not run properly if the nursing process does not properly implemented.Keywords: Management of Care of Nursing, Quality of Service, standard nursing process,

Ponatinib: A Review of Efficacy and Safety

2018 ◽  
Vol 18 (9) ◽  
pp. 847-856 ◽  
Author(s):  
Fulvio Massaro ◽  
Matteo Molica ◽  
Massimo Breccia
Keyword(s):  
Kinase Inhibitor ◽  
Tolerability Profile ◽  
Third Generation ◽  
Efficacy And Safety ◽  
Future Perspectives ◽  
General Management ◽  
T315i Mutation ◽  
Baseline Characteristics ◽  
Management Recommendations ◽  
Cardiovascular Profile

Ponatinib is a third generation kinase inhibitor designed to overcome the gatekeeper T315I mutation. In different trials this drug showed inhibitory activity against native BCR-ABL1 kinase and several ABL1 mutations. For this reason, ponatinib is currently indicated for the treatment of chronic myeloid leukaemia (CML) in every phase of disease resistant and/or intolerant to dasatinib and nilotinib and for whom imatinib is not indicated anymore or for patients with T315I mutation. The drug is also indicated for Ph+ acute lymphoblastic leukaemia (ALL). Ponatinib was temporarily suspended in 2013 for the occurrence of cardiovascular thrombotic events. Since then, different investigators analyzed baseline characteristics of patient candidates for ponatinib, especially cardiovascular profile, in order to describe general management recommendations in this setting. In this review, clinical trials data about the use of ponatinib in CML and Ph+ ALL patients will be discussed. It will be focused also about the safety and tolerability profile of the drug and future perspectives of employment.

scholarly journals Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians

2021 ◽  
Author(s):  
Konstantina Rosiou ◽  
Christian Philipp Selinger
Keyword(s):  
Ulcerative Colitis ◽  
Rescue Therapy ◽  
Medical Emergency ◽  
Close Monitoring ◽  
Surgical Morbidity ◽  
Severe Ulcerative Colitis ◽  
General Management ◽  
Management Measures ◽  
Management Advice ◽  
Team Setting

AbstractAcute severe ulcerative colitis is a medical emergency that warrants in-patient management. This is best served within a multidisciplinary team setting in specialised centres or with expert consultation. Intravenous corticosteroids remain the cornerstone in the management of ASUC and should be initiated promptly, along with general management measures and close monitoring of patients. Unfortunately, one-third of patients will fail to respond to steroids. Response to intravenous corticosteroid therapy needs to be assessed on the third day and rescue therapies, including cyclosporine and infliximab, should be offered to patients not responding. Choice of rescue therapy depends on experience, drug availability and factors associated with each individual patient, such as comorbidities, previous medications or contra-indications to therapy. Patients who have not responded within 7 days to rescue therapy must be considered for surgery. Surgery is a treatment option in ASUC and should not be delayed in cases of failure of medical therapy, because such delays increase surgical morbidity and mortality. This review summarises the current management of acute severe ulcerative colitis and discusses potential future developments.

Sign in / Sign up

Export Citation Format

Share Document